chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Per patient portal message to the Doctor, "I am not asking for a medical response, I am reporting this so that it can be a part of my medical notes. On 03-30-21 I had my second Pfizer vaccine. a few days later I had some sharp pain in my left breast which traveled into my heart. All of this lasted no more than a few hours. On 10-19-21 after my third Pfizer vaccine I was fine for the first three days, then i started getting a sharp pain right under my heart, near the breast bone. It was intermittent say maybe eight times throughout the next day. the pain moved into my left breast and traveled by that night into my heart. This pain was sharp but happened no more than 8 to 10 times throughout the day and evening. The duration of this pain was only seconds long and lasted about two and a half days. As they reoccurred the frequency and pain lessoned. I have had no other symptoms since that day. I questioned myself about if it was a medical emergency and decided it was not."
Developed Hives, especially around the Neck, Scratchy throat as well as hoarseness. I gave myself BENEDRYL 25mg orally at time of Reaction: at 24 hours past Reaction still with Hoarseness, otherwise recovered.
Pt received meningitis vaccine on Mon 8/22/05 in the ballroom of the student center and by 8/23/05 had a fever (102.1) and a stiff neck with normal BP and P. By 8/24/05 he better
This case was reported by a healthcare professional and described the occurrence of concentration difficulty in a female subject aged between 50 and 59 years old who was vaccinated with Engerix B (GlaxoSmithKline) for prophylaxis.  On 20 September 2007 the subject received the first dose of Engerix B (intramuscular, right deltoid).  The reporter noted that the subject "was skinny and had a very small deltoid muscle in which to inject the Engerix B".  On 20 September 2007, on the same day as vaccination with Engerix B, the subject experienced concentration difficulty, which resolved that same day.  On 21 September 2007, the subject experienced aching in the right arm, which resolved approximately one week later.  At the time of reporting the events were resolved.  The vaccination course with Engerix B was discontinued.  Follow-up received on 24 October 2007 via the healthcare professional.  The onset date of the earliest signs and symptoms was reported to be 30 August 2007.  She noted that the end date was questionably on 07 September 2007.  It was reported that concentration returned the next day and the arm was sore for one week.  The nurse noted that the outcome of the events improved and resolved.  She noted that the events were not related to the use of Engerix B and were not serious.  The nurse also reported that she had received an email from the subject.  The subject stated that "she had the devil's own job concentrating."  She also stated that her arm was fine until the next day and then it ached for at least a week.  Follow-up received on 25 October 2007 from the nurse indicated that the Engerix B start date of 20 September 2007 was in error.  She stated that the subject received Engerix B on 30 August 2007.  She reported that she did not know the specific date that the events resolved other than in September 2007.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 13-APR-2016, the patient was vaccinated with an improperly stored dose of ROTATEQ (orally, dose was not reported, lot # L035508, expiration date 12-MAY-2017). There was no adverse effect reported. The administered dose of vaccine experienced the temperature excursion of 47 degrees Fahrenheit for 144 hours. There was no data logger involved. There were no previous excursions reported. This is one of several reports received from the same source. Additional information has been requested.
respiratory; sore throat; ear infection; congestion; cough; cough progressively worsened and became productive; low grade fever; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A 15-year-old male patient received BNT162b2 (BNT162B2), on 06Jan2022 as dose 3 (booster), single (Lot number: FL3209) at the age of 15 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: DOXYCYCLINE taken for acne. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Site of injection: L. arm (Left Arm), Covid-19 Vaccine name: Pfizer, Batch/Lot number: EW0167), administration date: 17May2021, when the patient was 14-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 2, SINGLE, Site of injection: L. arm (Left Arm), Covid-19 Vaccine name: Pfizer, Batch/Lot number: EW0191), administration date: 09Jun2021, when the patient was 14-year-old, for COVID-19 Immunization. The following information was reported: COUGH (non-serious) with onset 09May2022, outcome "unknown"; PRODUCTIVE COUGH (non-serious) with onset 09May2022, outcome "unknown", described as "cough progressively worsened and became productive"; PYREXIA (non-serious) with onset 09May2022, outcome "unknown", described as "low grade fever"; NASAL CONGESTION (non-serious) with onset 18May2022, outcome "unknown", described as "congestion"; EAR INFECTION (non-serious) with onset 20May2022, outcome "unknown"; RESPIRATORY DISORDER (non-serious), outcome "unknown", described as "respiratory"; OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "sore throat". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: It was unknown whether patient have Sars-CoV2 antibodies at diagnosis. The patient was not hospitalized. The patient was not admitted to an intensive care unit. The patient did not display clinical signs at rest indicative of severe systemic illness. Patient had cough and sore throat during initial 10 days. Cough progressively worsened and became productive week of 09May2022. One day of low grade fever. Congestion began 18May2022 and ear infection documented 20May2022. Patient's outcome with Covid-19 was recovering. It was unknown from how many days from SARS-CoV2 diagnosis did it take before the SARS-CoV2 antigen test became negative. The patient was not a smoker/former smoker. The patient was taking other medication routinely prior to the event being reported which included: MVI, Doxycycline 50 mg 2 tab QD for acne. The patient did not have any pre-existing disease worsened during the SARS-CoV2 infection. The patient had not been treated with immunomodulating or immunosuppressing medication or received any other vaccines around the time of covid-19 vaccination.  No follow-up attempts are possible. No further information is expected.
Pretty severe sore throat; Hard to sleep; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Pretty severe sore throat), INSOMNIA (Hard to sleep), CHILLS (Chills) and HEADACHE (Headache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced CHILLS (Chills) and HEADACHE (Headache). On 14-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Pretty severe sore throat) and INSOMNIA (Hard to sleep). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (Pretty severe sore throat), INSOMNIA (Hard to sleep), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.            No relevant concomitant medications were provided.  The patient received lozenges as treatment.  Action taken with mRNA-1273 in response to the event was not applicable.
A week after receiving vaccine, the patient had enlargement of right breast and hardness around right nipple, which is now resolved. No redness or drainage.
Patient recieved Adacel on 6/16/07.  She  complained of mild swelling and pain at injection site, starting 1 day after injection.  She noted that pain and swelling became progressively worse starting on day 4 (06/20/07)post injection through her presentation on day 6 post-injection (06/22/07).  Upon exam of injection site (left arm, deltoid muscle) - pt had a slightly raised, erythematous patch (approximately 4" across by 2 1/2" high), with approximately 1/2" diameter induration under the injection site.  The site was HOT to touch and tender to palpation.  There was no visible exudate. The patients temperature was 98.1, heart rate - 72.  The patient last had DTP in 1987; patient has no medical history, and was taking only oral contraceptive pills for medication.  Diagnosis is sterile abcess. Treatment for patient is Cephalexin 500mg by mouth three times a day for 10 days.  I also reccomended warm compresses at injection site, and tylenol for pain/swelling.
Experienced severe acid reflux with white, coated tongue for 3 days 4th and 5th days nausea, headache, chills aching joints from neck to feet on 2/19 left arm sore (it was not sore except for day after injection) and itchy
PNEUMOVAX 23 inj. in left upper arm; 4-6 hrs. later severe swelling, site warm and light red; "hard" muscle to touch and pain in upper arm. Symptoms were still present 12/23 with swelling of entire upper left arm/warmth/light red. 12/24/17 still pain at inj. site and inner upper arm still swollen.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On an unknown dates, the patients were vaccinated with an improperly stored dose of ZOSTAVAX (lot# L003215 with expiration date 30-APR-2016; lot# L029485 with expiration date 06-NOV-2016; dose, anatomical location and route of administration were not reported). The vaccines were exposed to 4 hours 30 minutes at 47.5 Fahrenheit (F) on the fifth of April (year unspecified), 1 hour 30 minutes at 51.3 F, 2 hours at 56.3 F and 30 minutes at 6.1 F on the seventh of April (year unspecified), 1 hour and 30 minutes at 48.9 F on the fifth of May (year unspecified) and 1 hours at 51.6 F on the sixth of May (year unspecified). No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Fever (100) - Took Motrin Nausea - Went away after a few hours Sweats - Went away after a few hours
This spontaneous report was received from a healthcare professional who reported that in January 2014, 21 improperly stored doses of ROTATEQ, (oral, dose, batch and lot number not reported) were administered by a clinic to an unspecified number of patients (age and gender were not reported). No adverse effects were reported. This is one of several reports from the same source. Follow up information has been received on 17-MAR-2014. All telephone attempts to obtain follow-up information had been unsuccessful. Follow up information has been received on 22-SEP-2014. Demographic details for each patient were provided. This report referred to an 8-months old male patient, with no known drug allergies and no illness at time of vaccination. The patient was vaccinated with the second dose of ROTATEQ (oral, batch/lot # J004875, expiration date 17-OCT-2014), on 15-JAN-2014. It was reported that this dose was spoiled since the refrigerator was too cold (onset of event also reported as 27-FEB-2014 at 10:00 AM). The parents of the patient were going to consult with physician and declined to repeat the dose. No adverse event was reported for the patient. This is one of several reports from the same source. Additional information is not expected since all follow ups requested to complete the case were received.
Fatigue, chills, fever  Took ledum, thuja, rhus tox, gelsemium and chelidonium plex to treat symptoms till they resolved.
Ever since the 2nd Covid shot on July 27, 2021, I've had shortness of breath, pressure in my chest, that worsen after the booster shot that was administered on January 29,2022.  The pain in my chest feels like a slight compression and throbbing sensation.  I also have an throbbing sensation on the right dide of the neck, and my vision is completely blurred without reading glasses.  I also have a lingering  headache and fatigue.
Information has been received from a nurse practitioner concerning a 15 year old female patient who in November 2006, was vaccinated with GARDASIL IM for her first dose. The patient experienced flu like reactions after the first dose such as headache, fever, nausea and dizziness. The patient received the second dose of GARDASIL IM on 09-JAN-2007 and experienced sore arm (unspecified which arm). The patient received the third dose of GARDASIL IM on 24-MAY-2007. The patient was having unusual joint pain (all over but mostly in the knees), excessive fatigue, moments of shortness of breath, lots of muscle weakness, period of stomach aches, dizziness (may have been related to fluid in the ears), and chest pain on exercising. It was unspecified the time period all these symptoms occurred. The patient remembered having stomach problems but not sure as to the timing of the onset of the problem in relation to the third dose. The patient was last seen in the office on 22-JAN-2009 and was not doing any better. The patient had also sought medical attention by phone calls and office visits. Additional information has been requested.  3/6/09 Received PCP medical records of 4/12/2008-1/27/2009. FINAL DX: polyarthralgia Records reveal patient experienced feeling feverish, sore throat, fall from horse w/o LOC or injury then developed frontal HAs, LUQ pain after meals, fatigue.  RTC 10/08 w/left hip pain, dx w/greater trochanter tendinitis w/early ileatal band syndrome.  RTC 12/08 w/dry nonproductive cough x 2 wks, dx bronchitis & tx w/oral antibiotics.  RTC 1/09 w/recurrent cough, difficulty breathing, fatigue, muscle aches, HA & dizziness.  Dx w/recurrent bronchitis.  RTC 1/14 w/persisting HA, resolved dizziness & persistent muscle/joint aching.  RTC 1/27/09 & reports having flu-like s/s after initial HPV vaccine.  Referred to Neuro when CT head neg but no record available.
A couple of days after getting my vaccine, my whole ring around my mouth became enflamed, red, itching, and peeling for about two weeks. I went to the doctor who prescribed Valtrex antiviral drug for 3 days at a high dosage to help the irritation. About 5 days post-prescription, the hives and irritation around my mouth went away.
Had pain, swelling g and redness the first 3 days and then it went away. A week later it has now gotten hot, red and continues to grow. I have a purple center with whitish ring and red outer ring. Itchy, swollen and hot.
Redness and swelling of legs below the knee with non-blanching rash, apply mild moisturizer, symptoms were gone within 72 hours.
Patient received 2 PREVNAR vaccines. The first administered on 02/16/15 and 2nd on 4/15/16. No adverse events reported per patient.
I have a stiff neck but that may be from sleeping.; Three hours after receiving the vaccine I felt a burning sensation at the top of my head; The area of my head where it occurs has changed some but always around the very top of my head.; My whole scalp felt hot,; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 16Aug2021 12:00 (Lot number: FD8448) at the age of 63 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "hip replacement" (unspecified if ongoing); "Hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID. Past drug history included: Codeine, reaction(s): "Known allergies codeine", notes: Codeine and sinus products over the counter. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious) with onset 16Aug2021 15:00, outcome "not recovered", described as "I have a stiff neck but that may be from sleeping."; BURNING SENSATION (non-serious) with onset 16Aug2021 15:00, outcome "not recovered", described as "Three hours after receiving the vaccine I felt a burning sensation at the top of my head"; HEAD DISCOMFORT (non-serious) with onset 16Aug2021 15:00, outcome "not recovered", described as "The area of my head where it occurs has changed some but always around the very top of my head."; FEELING HOT (non-serious) with onset 16Aug2021 15:00, outcome "not recovered", described as "My whole scalp felt hot,". Therapeutic measures were not taken as a result of musculoskeletal stiffness, burning sensation, head discomfort. Therapeutic measures were taken as a result of feeling hot.  Additional information: Facility type vaccine was Pharmacy or Drug Store. If other vaccine in four weeks was no. Other medications in two weeks was Synthroid 1.15. It was reported that Three hours after receiving the vaccine I felt a burning sensation at the top of my head, it lasted only a few sections then stopped, it happened again 3 times that day. It felt like my blood pressure was up but it wasn't. The second day it happened again but not with the same burning sensation, it happened a couple of more times. This is the third day it has happened several more times but not as painful as the first day. The area of my head where it occurs has changed some but always around the very top of my head. My whole scalp felt hot, I placed an ice pack on it which felt better. I have a stiff neck but that may be from sleeping. My concern is my brain being affected in some way. If covid prior vaccination and If covid tested post vaccination was no.  Follow-up attempts are completed. No follow-up attempts are possible. No further information is expected.
Soreness at the site, redness 2 inches below the injection site, area is tender to the touch/painful/swollen/hard/itchy, pt does not want to wear sleeves due to discomfort. PRN Tylenol 500 mg PO Q6 hr as needed for pain.
Chills; fever; soreness; sleepy; This is a spontaneous report received from a contactable consumer (patient). A 62-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248, expiry date unknown), via an unspecified route of administration in the left arm, on 28Jan2021 08:00, as single dose, for COVID-19 immunization. The patient medical history was not reported. The patient was not pregnant at the time of vaccination. Concomitant medication included vitamins. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. The patient experienced chills, fever, soreness, and was sleepy on 28Jan2021 (reported as 03:30 AM, pending clarification). No treatment was given for the events. The outcome of the events was not resolved. The reporter assessed the events as non-serious.
RECEIVED ANTHRAX VACCINE ON 11/29/2018 AND REPORTED TO ER ON 11/30/2018 AT 2200 WITH PAIN/REDNESS AND TIGHTNESS TO LEFT UPPER EXTREMITY, VACCINE GIVEN IN L DELTOID. PEPCID 20MG PO AND PREDNISONE 40MG PO ADMINISTERED AT 0109 ON 12/01/2018 IN ER. MEDROL DS PACK, BENADRYL, AND PEPCID PRESCRIBED.
I am currently 29 years old and have received one dose of Gardasil 4; No other AE.; This spontaneous report was received from a Consumer and refers to a currently 29-year-old patient of unknown gender.  The patient's medical history, concurrent conditions, and concomitant therapies were not provided.  On an unknown date, the patient was vaccinated with first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection, administered for prophylaxis (anatomical location) strength, lot #, expiry date, and route of administration were not provided) (product administered to patient of inappropriate age). No other adverse events.
Swelling under the left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling under the left arm) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swelling under the left arm). At the time of the report, VACCINATION SITE SWELLING (Swelling under the left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was reported.
1-11 Wed AM had vaccines-soreness. Wed PM very sore, hard to walk (R) leg. 1-12 Thurs-increased soreness, swollen and red-BENADRYL given. 1-13 Friday-knee to hip red, swollen, itching BENADRYL given. Office visit-BENADRYL and ORAPRED given, also Rx for cephalexin for 10 days.
I started feeling very tired and lightheaded. I was not due for my period, and I started my period, and it was very heavy. I had body aches and chills as well.
MMR, Varicella, Influenza vaccine administered on Oct 27 2005. Red, papular rash began Nov 1 on trunk, spread to extremities, face. later developed mild cough 4 days after onset of rash.
Severe swelling in arm. Large red welts. Temperature of 103 with fever and chills